Neuroimmune dysregulation and comorbidity mechanisms of major depressive disorder and migraine

• by Guining Liang, Qi Huang, Wenyi Song, Mika Pan, Qingyan Wei, Jingyi Zeng, Youfeng Xie, Yating Lan, Chun Zou, Xiuying Liu, Xiaohua Huang, Donghua Zou

• January 14, 2026

CGRP Therapies May Reduce Migraine Days

Systematic review found high-certainty evidence for several calcitonin gene–related peptide–targeted therapies.

• by Andrea Surnit

• May 20, 2026

• 3 min

Bridging the gap: molecular mechanisms, regional activity and connectivity in headache disorders

• by Linda Kollenburg, Erkan Kurt, Wim Mulleners, Hisse Arnts, Christopher Louis Robinson, Janneke Poelen, Kaare Meier, Moises Dominguez, Sait Ashina, Kris Vissers

• September 25, 2025

Astigmatism Up After COVID Restrictions

Researchers identified delayed corneal changes in schoolchildren that emerged after myopia rates had already increased during the pandemic.

• by Kathryn Wighton

• May 12, 2026

• 5 min